Very red day for Moderna Inc. stock price after -6.60% fall in Monday trading session

The Moderna Inc. stock price fell by -6.60% on the last day (Monday, 13th Sep 2021) from $449.38 to $419.72. and has now fallen 3 days in a row. During the day the stock fluctuated 8.15% from a day low at $415.00 to a day high of $448.81. The price has risen in 6 of the last 10 days and is up by 9.81% over the past 2 weeks. Volume has increased on the last day by 3 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 16 million shares were bought and sold for approximately $6.54 billion.

On September 12, 2021 "SVB Leerink" gave "" rating for MRNA. The price target was changed from $449.38 to 1.4%.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $408.79 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift.Given the current short-term trend, the stock is expected to rise 83.51% during the next 3 months and, with a 90% probability hold a price between $750.17 and $1 075.51 at the end of this 3-month period.

The Moderna Inc. stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $428.38. On a fall, the stock will find some support from the long-term average at approximately $395.97. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, August 09, 2021, and so far it has fallen -13.37%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Moderna Inc. finds support from accumulated volume at $419.05 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $33.81 between high and low, or 8.15%. For the last week, the stock has had a daily average volatility of 6.24%.

Moderna Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.